|
RNF214 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64968039229052E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.85759971241362E-10 |
| Normal-vs-Stage2 |
3.37119999693769E-08 |
| Normal-vs-Stage3 |
1.08246744900953E-13 |
| Normal-vs-Stage4 |
1.30239996565251E-09 |
| Stage1-vs-Stage2 |
3.163000E-01 |
| Stage1-vs-Stage3 |
6.401600E-03 |
| Stage1-vs-Stage4 |
9.847800E-02 |
| Stage2-vs-Stage3 |
3.241600E-01 |
| Stage2-vs-Stage4 |
5.952200E-01 |
| Stage3-vs-Stage4 |
6.886800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.56239474083486E-13 |
| Normal-vs-AfricanAmerican |
5.78559999999673E-05 |
| Normal-vs-Asian |
8.09580000000754E-05 |
| Caucasian-vs-AfricanAmerican |
8.447200E-01 |
| Caucasian-vs-Asian |
7.790400E-02 |
| AfricanAmerican-vs-Asian |
3.289400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.14115400357196E-12 |
| Normal-vs-Female |
2.31847874232471E-12 |
| Male-vs-Female |
2.939000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.22349957626989E-10 |
| Normal-vs-Age(41-60Yrs) |
2.59799959323459E-11 |
| Normal-vs-Age(61-80Yrs) |
1.89781523829424E-12 |
| Normal-vs-Age(81-100Yrs) |
1.58289999996342E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.198040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.097500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.457700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.640600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.824490E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.686800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.217440E-04 |
| Classical-VS-Follicular |
1.216400E-01 |
| Classical-VS-Other |
7.520800E-01 |
| Classical-VS-Normal |
1.57469592920734E-11 |
| Tall-VS-Follicular |
4.862500E-02 |
| Tall-VS-Other |
1.590170E-01 |
| Tall-VS-Normal |
2.68807198722243E-12 |
| Follicular-VS-Other |
8.208400E-01 |
| Follicular-VS-Normal |
2.89820001331265E-09 |
| Other-VS-Normal |
1.078260E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.61901611509074E-12 |
| Normal-vs-N1 |
7.64490000193518E-08 |
| N0-vs-N1 |
9.968200E-01 |
|
|
